• skip to main content
  • skip to main navigation
  • skip to useful links

SCOTTISH MEDICINES CONSORTIUM

NHS SCOTLAND

Providing advice about the status of all newly licensed medicines


Useful Liks

  • Contact Us
  • Feedback
  • Links
  • Subscribe
  • Glossary
  • Site Map

  • Home
  • Work Programme
  • Submission Process
  • Public Invovlement
  • Horizon Scanning
  • SAPG
  • About Us
  • FAQs

  • Membership
  • Minutes
  • Policy Statements
  • Experts
  • Publications
  • Events
  • Contact Us

Policy Statements

Declarations of Interest
SMC policy statement regarding Declarations of Interest

Licensing of Medicines
SMC policy statement regarding Licensing of Medicines

Meetings with Manufacturers
SMC policy statement regarding meetings with Manufacturers

Orphan Diseases
SMC policy statement regarding Medicines for Orphan Diseases

SMC Modifiers
SMC policy statement regarding modifiers used in appraising new medicines

Post-Code Prescribing
SMC policy statement regarding Post-Code Prescribing

Process for Reviewing Decisions
SMC policy statement regarding the process for Reviewing Decisions

Release of Economic Checklist to Industry
SMC policy statement regarding the release of the Economic Checklist to Industry - Updated October 2009

Release of Company Data
Agreement between ABPI and SMC re the release of company data into the public domain

Consistent SMC and SIGN Advice on New Medicines for NHSScotland
Process in relation to consistent advice from SMC and SIGN

SMC process for issuing ‘not recommended’ advice due to non-submission by a pharmaceutical company
Process for issuing 'not recommended' advice due to a non-submission

 

 


Useful Links

  • Back to top
  • Low Graphics Version
  • Accessibility
  • Freedom of Information
  • Terms & Conditions